Research and Development

An imaging agent that can detect amyloid plaques in the brains of Alzheimer’s patients and so may provide an accurate …

Oxford BioTherapeutics has expanded its US operations, recruiting a number of senior industry leaders.Dr Jim Cornett will head up operations …

 The French government has agreed a new deal with industry leaders to help the country’s pharma and biotech industries.President Sarkozy …

Pharmaceutical Product Development (PPD) has expanded its capacity to offer drug development services in Asia once again with the acquisition …

Venture capital is a curious business and the global financial crisis in which we find ourselves has exposed some rather …

Novartis has paid Incyte Corporation $150 million up front for the rights to two oral investigational hematology-oncology therapies.The first is …

ExonHit Therapeutics appoints Hervé Duchesne de Lamotte chief financial officer.The Paris-based company develops innovative molecular diagnostic tests and therapeutics for …

GlaxoSmithKline Biologicals has signed a licensing agreement for a nicotine vaccine candidate currently in the first of two phase III …

Pharmafocus’ latest round-up of clinical research news includes a new US registry to aid patient recruitment, alliances for ICON, Parexel …

The European Agency for the Evaluation of Medicinal Products was set up in 1995 in London’s Docklands, an isolated eastern …

Roche is investing in a Spanish health authority programme to analyse the genomes of people with rare diseases.The pharma company …

Pfizer UK’s Zubair Hussain has been appointed president-elect of global regulatory affairs organisation TOPRA.

Dr Jan Lundberg has been appointed executive VP, science and technology, and president of Lilly Research Laboratories.He will succeed Dr …

 China’s allure for pharma companies continues unabated with Merck Serono’s opening of a research and development centre in Beijing. The …

 Sanofi-Aventis has put more financial muscle behind its partnership with Regeneron for the development of monoclonal antibody-based drugs, boosting its …